Fast forward to today, and we have the modern titans: Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)
Methodology The databases of Web of Science, PubMed, and Google Scholar were searched for this narrative review by the following keywords: hypertension, blood pressure, hypotensive, antihypertensive, hypertensive, diuretic, diabetes, hyperglycemia, insulin, hypoglycemic, antihyperglycemic, antidiabetic, blood glucose, HbA1c, dyslipidemia, hyperlipidemia, high cholesterol, high triglyceride, hypercholesterolemia, hypertriglyceridemia, hypoglycemic, hypolipidemic, hypoglycaemic, hypolipidaemic, lipid-lowering, atherogenic, atherosclerosis, obesity, overweight, appetite, anti-obesity, weight loss, bodyweight, food intake, feed intake, metabolic syndrome, metabolic syndromes, metabolic syndrome X, insulin resistance syndrome, dysmetabolic syndrome X, reaven syndrome X, metabolic cardiovascular syndrome, cardiometabolic syndrome, cardiometabolic syndromes, Withania somnifera , winter cherry, Indian ginseng, ashwagandha, withanias, withaferins, withanolides and withanosides
& Barco, A
If you started a GLP-1 a year ago with a BMI of 38 and you are now down to 33, your prescriber attests to the higher number and you still qualify
